Sangamo Therapeutics | 4:持股变动声明-高管 Duraibabu Prathyusha
Sangamo Therapeutics | 4:持股变动声明-董事 Smith Karen L.
Sangamo Therapeutics | 4:持股变动声明-董事 Horn Margaret A
Sangamo Therapeutics | 4:持股变动声明-董事 Markels John
Sangamo Therapeutics | 4:持股变动声明-董事 Meyers James R
Sangamo Therapeutics | 4:持股变动声明-董事 PARKER H STEWART
Sangamo Therapeutics | 4:持股变动声明-董事 Hillan Kenneth J.
Sangamo Therapeutics | 4:持股变动声明-董事 Carey Robert
Sangamo Therapeutics | 4:持股变动声明-董事 Beers Courtney
Sangamo Therapeutics | 8-K:重大事件
Sangamo Therapeutics | 4:持股变动声明-高管 Dubois-Stringfellow Nathalie
Sangamo Therapeutics | 4:持股变动声明-高管 Willoughby Scott B.
Sangamo Therapeutics | 4:持股变动声明-高管 Pooler Amy
Sangamo Therapeutics | 4:持股变动声明-高管 Duraibabu Prathyusha
Sangamo Therapeutics | 4:持股变动声明-高管 Macrae Sandy
Sangamo Therapeutics | 10-Q:季度报表
Sangamo Therapeutics | 8-K:SANGAMO THERAPEUTICS公布了最近的业务亮点和2024年第一季度财务业绩
Sangamo Therapeutics | 8-K:重大事件
Sangamo Therapeutics | ARS:年度报告
Sangamo Therapeutics | DEF 14A:股东委托书决议
暂无数据